positron-emission-tomography

Documents about positron-emission-tomography

• This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.#901793ClinicalTrials.gov
• Yeni̇ tanı di̇ffüz büyük b hücreli̇ lenfoma hastalarında kli̇ni̇k prognosti̇k faktörler i̇le FDG PET/BT'de tüm vücut metaboli̇k tümör volümünün hastalık sağkalımı üzeri̇ne etki̇si̇#203165Recep Tayyip Erdoğan University Institutional Repository
• A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer#804906ClinicalTrials.gov
• The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy#831034ClinicalTrials.gov
• Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial#1029782ClinicalTrials.gov
• Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography#837276ClinicalTrials.gov
• Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment#875816ClinicalTrials.gov
• Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment#1015715eScholarship
• A Head-to-Head Comparison Between [18F]Fluorodeoxyglucose ([18F]FDG) Positron Emission Tomography/Computed Tomography (PET/CT) and 99m Technetium-Hexamethylpropilene Amine Oxime (HMPAO)-Labeled Leuhocyte Scintingraphy in a Case Series of Patients with Suspected Vascular Prosthesis Infection: To Trust Is Good, but to Check Is Better#430418IRIS
• Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)#890909ClinicalTrials.gov
• 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy#810930ClinicalTrials.gov
• Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer#851279ClinicalTrials.gov
• Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas#881937ClinicalTrials.gov
• Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA#895109ClinicalTrials.gov
• Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET#847066ClinicalTrials.gov
• Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial#882479ClinicalTrials.gov
• Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease#895597ClinicalTrials.gov
• Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)#911617ClinicalTrials.gov
• PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol#630425HAL (France)
• Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients#825729ClinicalTrials.gov
• Positron Emission Tomography for Detecting Non-small Cell Lung Cancer#826743ClinicalTrials.gov
• 21 CFR Part 212 — Current Good Manufacturing Practice for Positron Emission Tomography Drugs#506801Code of Federal Regulations (eCFR)
• ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.#899611ClinicalTrials.gov
• A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach#871760ClinicalTrials.gov
• FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD#898586ClinicalTrials.gov
• Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer’s disease#164142Open Access LMU
• A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls#883366ClinicalTrials.gov
• Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer#901953ClinicalTrials.gov
• Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer#1046854ClinicalTrials.gov
• A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept#874316ClinicalTrials.gov